je.st
news
Weekly Analysts' Ratings Changes for Regeneron Pharmaceuticals
2015-08-27 14:16:29| Biotech - Topix.net
They now have a $565.00 price target on the stock. 8/20/2015 - Regeneron Pharmaceuticals was upgraded by analysts at Vetr from a "buy" rating to a "strong-buy" rating.
Tags: ratings
weekly
analysts
pharmaceuticals
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||